Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Nano-engineering offers unique solutions for biomedical implants to meet compromised patient conditions via enhanced bioactivity and local drug release. This book presents the cutting-edge nano-engineered dental implant solutions that has the potential to ensure long-term success of dental implants while maintaining clinical translatability. From surface modification of titanium/zirconium dental implants to advanced therapeutic enhancements to treat infection and poor integration, this book advances the field of dental implant nano-engineering, showcasing current trends and future directions.

Technology: general issues --- History of engineering & technology --- endocytosis --- ipriflavone --- mesoporous nanospheres --- nanoparticles --- oxidative stress --- pre-osteoblasts --- implant --- nano-scaled surface --- blood clot --- LncRNA --- osseointegration --- bone regeneration --- zirconium --- zirconia --- dental implants --- nanopores --- electrochemical anodization --- extracellular vesicles --- exosomes --- nanomedicine --- regeneration --- cell-free therapy --- decontamination --- antibacterial agents --- nano-modified dental implant --- nanostructured titanium --- dental implant --- TiO2 nanotubes --- surface modification --- antibacterial --- titanium --- laser therapy --- peri-implantitis --- debridement --- implants --- nanostructure --- gingival fibroblasts --- biofilm --- soft-tissue integration --- n/a

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Nano-engineering offers unique solutions for biomedical implants to meet compromised patient conditions via enhanced bioactivity and local drug release. This book presents the cutting-edge nano-engineered dental implant solutions that has the potential to ensure long-term success of dental implants while maintaining clinical translatability. From surface modification of titanium/zirconium dental implants to advanced therapeutic enhancements to treat infection and poor integration, this book advances the field of dental implant nano-engineering, showcasing current trends and future directions.

endocytosis --- ipriflavone --- mesoporous nanospheres --- nanoparticles --- oxidative stress --- pre-osteoblasts --- implant --- nano-scaled surface --- blood clot --- LncRNA --- osseointegration --- bone regeneration --- zirconium --- zirconia --- dental implants --- nanopores --- electrochemical anodization --- extracellular vesicles --- exosomes --- nanomedicine --- regeneration --- cell-free therapy --- decontamination --- antibacterial agents --- nano-modified dental implant --- nanostructured titanium --- dental implant --- TiO2 nanotubes --- surface modification --- antibacterial --- titanium --- laser therapy --- peri-implantitis --- debridement --- implants --- nanostructure --- gingival fibroblasts --- biofilm --- soft-tissue integration --- n/a

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Nephropathic cystinosis (MIM # 219800) is a rare autosomal recessive disorder caused by mutations in the lysosomal cystine transporter cystinosin, encoded by the CTNS gene (17p13.2). This devastating condition initially affects kidneys and subsequently many other organs including eyes, thyroid, pancreas, muscles, and brain. While lysosomal cystine storage is a key feature of the disease and the main target of current therapy, recent groundbreaking research has revealed that cystinosin has diverse functions in cells, being involved in vesicle trafficking, energy homeostasis, and cell death mechanisms. These discoveries deepen our insights into the mechanisms of cystinosis and of lysosomal biology in general. In this Special Issue dedicated to the pioneer of cystinosis research Dr. Jerry Schneider, we highlight the state-of-the-art understanding of cellular and molecular mechanisms of various disease features, opening new horizons for innovative treatment strategies for cystinosis and potentially other lysosomal storage diseases.

Medicine --- Pharmacology --- cystinosis --- cysteamine --- bone --- osteoclast --- genotype --- CD34+ hematopoietic stem and progenitor cells --- gene therapy --- pre-clinical studies --- investigational new drug application --- clinical trial --- disulfiram --- mice --- zebrafish --- fertility --- azoospermia --- hypogonadism --- histopathology --- mouse model --- lysosomal storage disease --- cell and animal models --- infantile nephropathic cystinosis --- bone-muscle wasting --- fibroblast growth factor 23 --- osteoclasts --- sclerostin --- leptin --- fractures --- nephropathic cystinosis --- hollow fiber membrane --- 3-dimensional models --- autophagy --- macrophages --- inflammasome --- proximal tubular cells --- endocytosis --- apoptosis --- chitotriosidase --- interleukins --- galectin-3 --- novel therapies --- endolysosome --- epithelial cell differentiation --- homeostasis --- lysosomal storage diseases --- mitochondrial distress --- kidney proximal tubule --- programmed cell death --- central nervous system --- cortical atrophy --- arterial spin labelling --- cystine blood level --- lysosomal storage disorder --- history --- treatment strategies for cystinosis --- newborn screening --- clinical course --- CTNS-pathogenic variants --- newborn screening for cystinosis --- kidney progenitors --- cell model --- biomarkers --- cystine --- kidney --- therapeutic monitoring

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

The aim of this Special Issue is to collect reports regarding all the recent strategies, directed at the improvement of antineoplastic activity of drugs in cancer progression, engaging all the expertise needed for the development of new anticancer drugs: medicinal chemistry, pharmacology, molecular biology, and computational and drug delivery studies.

Research & information: general --- Biology, life sciences --- EGR-1 --- flavonoid --- (E)-5-((4-oxo-4H-chromen-3-yl)methyleneamino)-1-phenyl-1H-pyrazole-4-carbonitrile --- MDA-MB-231 --- MMP9 --- TNFα --- pancreatic ductal adenocarcinoma --- cyclodextrin inclusion complex --- phase solubility studies --- preformulation studies --- biphenylnicotinamide derivatives --- dual inhibitor --- EGFR --- VEGFR2 --- ligand-based pharmacophore --- molecular docking --- molecular dynamics --- leukemias --- doxorubicin --- inflammation --- drug delivery --- tumor targeting --- elastin-like polypeptide --- cell penetrating peptide --- matrix metalloproteinase --- doxorubicin resistance --- photosensitizer delivery system --- PAMAM dendrimer --- photodynamic therapy --- cytotoxicity --- phototoxicity --- colorectal adenocarcinoma --- dicarboximides --- chemical synthesis --- apoptosis --- kinases --- anticancer --- gene profiling --- SAR --- biomarkers --- colorectal cancer --- early detection examination --- liquid biopsy --- personalized medicine --- tumor treatment --- exosomes --- ctDNA --- CTC --- cytotoxic activity --- pyrazole derivatives --- MTT assay --- ADMET analysis --- single-crystal diffraction --- FTIR spectroscopy --- NMR spectroscopy thermogravimetric analysis --- acute myelogenous leukemia --- platelets --- microparticles --- γδ T cells --- immunotherapy --- tumor resistance --- combination therapy --- tumor microenvironment --- immune checkpoint inhibitor --- neuroblastoma --- molecular iodine --- cyclophosphamide --- xenografts --- metronomic therapy --- tamoxifen --- CYP2D6 --- MCF-7 --- Ishikawa cells --- SERM --- TNBC --- uterotrophic --- α-mangostin --- poly(amidoamine) dendrimer --- targeted drug delivery --- biotin targeting --- glioblastoma multiforme --- squamous cell carcinoma --- antiparasitic therapy --- diclofenac --- indomethacin --- oleanolic acid derivative conjugates --- NF-κB --- Nrf2 --- MAPKs --- PSN-1 cells --- reactive oxygen species --- glioblastoma --- brain tumor --- extracellular vesicles --- pancreatic cancer --- paclitaxel --- clathrin --- endocytosis --- sulforaphane --- nicotine --- metalloproteinase-9 --- gastric cancer --- cell invasion --- Arylquin 1 --- colon cancer --- tumor progression --- azelastine --- oxidative stress --- autophagy --- mitotic catastrophe --- chronic myeloid leukemia --- imatinib --- tyrosine kinase --- ketoconazole --- P-glycoprotein --- drug efflux transporter --- non-small-cell lung cancer --- cisplatin resistance --- aldehyde dehydrogenase --- isothiocyanates --- disulfiram --- epithelial to mesenchymal transition --- aminopeptidase N --- acetamidophenones --- Schiff bases --- semicarbazones --- thiosemicarbazones --- inhibition of proliferation

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Long-term exposure to environmental toxicants is estimated to account for 70–90% of the risks of acquiring chronic ailments. Presently, chronic kidney disease and infertility affect a significant proportion of the world population, while research data indicate that exposure to toxic metals may contribute to the looming statistics. Alarming evidence suggests that exposure to the heavy metal cadmium may affect every stage of life, and exposure in early life may determine susceptibility to certain diseases in adulthood. Prevention of these outcomes requires avoidance of further environmental contamination, minimization of exposure, and reduction of toxic metals in food crops to the lowest achievable levels.

Public health & preventive medicine --- Trace elements --- hair --- children --- hazardous waste incinerator --- Constantí (Catalonia, Spain) --- blood lead level --- boatyard --- childhood --- lead poisoning --- fishing community --- lead weights --- β2-microglobulin --- cadmium --- creatinine clearance --- glomerular filtration --- N-acetyl-β-d-glucosaminidase --- nephron mass --- nephrotoxicity --- trace elements --- autopsy tissues --- temporal trends --- creatinine excretion --- glomerular filtration rate --- lead --- kidney --- endocytosis --- metallothionein --- flow cytometry --- proximal tubule epithelial cells --- OGTT --- minimal model --- glucose response mechanism --- genotoxicity --- aluminum chloride --- rats --- food --- farmer --- PTWI (provisional tolerable monthly intake) --- TWI (tolerable weekly intake) --- Monte Carlo simulation --- mercury --- obesogen --- lipid profiles --- hyperlipidemia --- elevated liver enzymes --- hexavalent chromium [Cr(VI)] --- mitochondrial fragmentation --- dynamin-related protein 1 (Drp1) --- mitochondrial respiratory chain complex I (MRCC I) --- reactive oxygen species (ROS) --- blood lead --- cellular immunity --- phagocytosis --- humoral munity --- immunosuppression --- insulin --- diabetes --- hyperglycemia --- hyperinsulinemia --- lipogenic --- β-cell toxicity --- stroke --- cerebrovascular accident --- heavy metal --- rare earth element --- case-control study --- mortality --- lifetime cadmium intake --- renal diseases --- urinary cadmium --- a follow-up study --- diet --- kidney function --- chronic kidney disease --- threshold limit --- tolerable intake level --- heavy metals --- birth weight --- preterm birth --- diet pattern --- Mediterranean diet --- pregnancy --- toxic metals --- reproduction --- testicular and ovarian structure --- n/a --- Constantí (Catalonia, Spain)